In summary, soy isoflavone inhibits the synthesis of fatty acid and promote fat oxidation in NAFLD rat liver by regulating the expression of SREBP-1c and PPARα. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.